A Study on the Effects of Muscarinic and Serotonergic Regulation by Bojanggunbi-tang on the Pacemaker Potential of the Interstitial Cells of Cajal in the Murine Small Intestine

Int J Med Sci. 2023 May 21;20(8):1000-1008. doi: 10.7150/ijms.83986. eCollection 2023.

Abstract

In traditional Korean medicine, the 16-herb concoction Bojanggunbi-tang (BGT) is used to treat various gastrointestinal (GI) diseases. In this study, we investigated the regulatory mechanism underlying the influence of BGT on the interstitial cells of Cajal (ICCs), pacemaker cells in the GI tract. Within 12 h of culturing ICCs in the small intestines of mice, the pacemaker potential of ICCs was recorded through an electrophysiological method. An increase in the BGT concentration induced depolarization and decreased firing frequency. This reaction was suppressed by cholinergic receptor muscarinic 3 (CHRM3) antagonists, as well as 5-hydroxytryptamine receptor (5HTR) 3 and 4 antagonists. Nonselective cation channel inhibitors, such as thapsigargin and flufenamic acid, along with protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) inhibitors, also suppressed the BGT reaction. Guanylate cyclase and protein kinase G (PKG) antagonists inhibited BGT, but adenylate cyclase and protein kinase A antagonists had no effect. In conclusion, we demonstrated that BGT acts through CHRM3, 5HTR3, and 5HTR4 to regulate intracellular Ca2+ concentrations and the PKC, MAPK, guanylate cycle, and PKG signaling pathways.

Keywords: Bojanggunbi-tang; Traditional medicine; gastrointestinal disease; interstitial cells of Cajal; pacemaker potential.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cholinergic Agents / metabolism
  • Cholinergic Agents / pharmacology
  • Interstitial Cells of Cajal* / metabolism
  • Intestine, Small / metabolism
  • Membrane Potentials
  • Mice
  • Mice, Inbred BALB C
  • Protein Kinase Inhibitors / pharmacology
  • Signal Transduction

Substances

  • Protein Kinase Inhibitors
  • Cholinergic Agents